Opérations
Qui sommes-nous ?
L’entreprise
Equipe
Nos bureaux
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Conseil en matière de dette
Equity Research
Levées de Fonds – Séries A, B, C ….
Stratégie et préparation de l’introduction en bourse
Industries
Services aux Entreprises
Consumer / Retail / E-commerce
Technologie industrielle
Life science et Santé
Software / TMT
Career
Evénements
Insights
News
Company News
Deal News
Carlsquare in the Media
Newsletter
Contactez-nous
Newsletter
FR
INT
DA
DE
SV
US
Main menu button
Equipe
Opérations
Contact
Equipe
Opérations
Contact
Actualités
Tout
Company News
Deal News
Equity Research
Events
Insights
Macro and markets
Media
Tout
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Tout
30 Mar 2026
Equity research, Svenska Aerogel Q4 2025: Momentum builds up for a breakthrough
Equity Research
Svenska Aerogel
18 Mar 2026
Equity Research, White Pearl Technology Group: Revenue surging 37%, yet a 60% peer discount defies logic
Equity Research
White Pearl Technology Group
02 Mar 2026
Equity Research ALM Equity Q4 2025: Higher profit with a thousand housing starts per year
Equity Research
ALM Equity
01 Mar 2026
Equity research Enrad, Q4 2025: A Sweden push to accelerate growth
Equity Research
Enrad
27 Fév 2026
Equity research Enrad, Q4 2025: Soft sales but order pipeline intact
Equity Research
Enrad
27 Fév 2026
Equity research Zinzino Q4 2025: Healthy scalability
Equity Research
Zinzino
26 Fév 2026
Equity Research ALM Equity, Q4 2025: Increased cash and improved prospects
Equity Research
ALM Equity
25 Fév 2026
Equity research Immunovia Q4 2025: Targeting Medicare sub-mission by mid-2026
Equity Research
Immunovia
25 Fév 2026
Equity research Zinzino Q4 2024: First impression - Margins significantly above our expectations
Equity Research
Zinzino
24 Fév 2026
Equity research Immunovia Q4 2025: First impression - Modest Q4 sales, targeting Medicare submission by mid-2026
Equity Research
Immunovia
22 Fév 2026
Equity research Enrad, Q4 2025: A profit for the quarter may be on the cards
Equity Research
Enrad
20 Fév 2026
Equity research Viva Wine Group Q4 2025: Delta profit surprise raises spirits
Equity Research
Viva Wine Group
20 Fév 2026
Equity research Angler Gaming, Q4 2025: A year defined by margin improvement
Equity Research
Angler Gaming
19 Fév 2026
Equity research Viva Wine Group Q4 2025: First impression - Better than expected as Delta surprises
Equity Research
Viva Wine Group
19 Fév 2026
Equity research Angler Gaming, Q4 2025: Another quarter with margins expansion
Equity Research
Angler Gaming
18 Fév 2026
Equity research White Pearl Technology Group: A growth and profitability engine at a discount
Equity Research
White Pearl Technology Group
16 Fév 2026
Equity Research KlaraBo, Q4 2025: Dividends and share buybacks support the share price
Equity Research
KlaraBo
16 Fév 2026
Equity research CDON, Q4 2025: Macro tailwinds and initiatives support outlook
Equity Research
CDON
13 Fév 2026
Equity research CDON Q4 2025: First impression - Good growth and encouraging 2027 target
Equity Research
CDON
13 Fév 2026
Equity Research KlaraBo, Q4 2025: Dividend on the shares was the best news
Equity Research
KlaraBo
1
2
3
4
…
64
